As of Feb 27
| -0.99 / -1.00%|
The 5 analysts offering 12-month price forecasts for Bio-Techne Corp have a median target of 108.00, with a high estimate of 118.00 and a low estimate of 96.00. The median estimate represents a +10.74% increase from the last price of 97.53.
The current consensus among 6 polled investment analysts is to Buy stock in Bio-Techne Corp. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.